Cancer Institute A national cancer institute
designated cancer center

Imaging Instrumentation


A Stanford image combining positron emission tomography (PET) and computed tomography (CT) scans of a patient with lung cancer.


Program researchers are pursuing a number of avenues for improving and expanding upon existing cancer imaging instrumentation. Among their many aims, they are developing new handheld instruments for imaging during surgery and new methods for assessing intracellular activity with greater detail.

Researchers are also working on strategies to merge anatomical (CT) and molecular (PET, etc.) imaging data to achieve a more refined, 3-D view of a tumor’s location and activity.

Preliminary findings show that in some instances, placing biochemical patient data within a detailed, 3-D representation of the patient’s anatomy offers significant advantages over standard 2-D PET/CT imaging during pre-procedural or pre-surgical planning. This work is carried out in collaboration with the 3D Medical Imaging Lab and the Molecular Imaging Program at Stanford (MIPS).

Scientific Goals

Program Researchers

Christopher Beaulieu, MD, PhD

Kim Butts, PhD

Bruce Daniel, MD

Gary Glazer, MD

Gary Glover, PhD

Michael Goris, MD, PhD

Robert Herfkens, MD

Debra Ikeda, MD

Butrus Khuri-Yakub, PhD

Gordon Kino, PhD

Craig Levin, PhD

Michael Moseley, PhD

Sandy Napel, PhD

Dwight Nishimura, PhD

John Pauly, PhD

Norbert Pelc, ScD

Andrew Quon, MD

Geoffrey Rubin, MD

Olav Solgaard, PhD

F. Graham Sommer, MD

Mark Schnitzer, PhD

Robert Sinclair, PhD

Daniel Spielman, PhD



Stanford Medicine Resources:

Footer Links: